Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancer

Despite adequate treatment, 50% of stage III locally advanced inoperable non-small cell lung cancer (NSCLC) patients have a locoregional relapse. Local control on early stages on the contrary, is as high as 85–90% with stereotactic body radiotherapy (SBRT). The addition of SBRT to conventional chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcibar, Olwen Leaman, Nadal, Ernest, Romero Palomar, Inmaculada, Navarro-Martin, Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Articles on Multimodal Management of Locally Advanced N2 Non-small Cell Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867744/
https://www.ncbi.nlm.nih.gov/pubmed/33569334
http://dx.doi.org/10.21037/tlcr-2020-nsclc-04

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867744/
https://www.ncbi.nlm.nih.gov/pubmed/33569334
http://dx.doi.org/10.21037/tlcr-2020-nsclc-04

Ejemplares similares